Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Detroit
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Detroit, MI

Studies commonly pay $75 to $4,500 per completed study

1,198 clinical trials are currently recruiting participants within 30 miles of Detroit. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,198studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Detroit right now

Top 25 of 1,198 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain Tumor, Recurrent, Brain Tumor N/A Observational 600 participants sought
Henry Ford Health System — Detroit, Michigan (4.6 mi) · Sponsor: GT Medical Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04427384)

Emsella Chair vs Sham for Male Sexual Dysfunction

Male Sexual Dysfunction, Ejaculatory Dysfunction N/A Interventional 117 participants sought
Corewell Health William Beaumont University Hospital — Royal Oak, Michigan (7.6 mi) · Sponsor: Corewell Health East
See eligibility & contact on ClinicalTrials.gov (NCT05370651)

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Age-Related Macular Degeneration, Geographic Atrophy N/A Interventional 125 participants sought
Oakland Ophthalmic Surgery — Birmingham, Michigan (12.6 mi) · Sponsor: VisionCare, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05438732)

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Large Cell Lymphoma, Diffuse, Relapsed Cancer Phase 2 Interventional 35 participants sought
Karmanos Cancer Center (Wayne State University) — Detroit, Michigan (4.6 mi) · Sponsor: Dipenkumar Modi
See eligibility & contact on ClinicalTrials.gov (NCT05852717)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital of Michigan — Detroit, Michigan (4.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Henry Ford Health System — Detroit, Michigan (4.6 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06790693)

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis Phase 2 Interventional 164 participants sought
WISPer Site in Detroit, MI — Detroit, Michigan (4.6 mi) · Sponsor: Mediar Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06967805)

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS) Phase 2 Interventional 40 participants sought
Wayne State University Physician Group Dermatology — Detroit, Michigan (4.6 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07213973)

A Study of the TheraBionic P1 Device in Breast Cancer

Breast Cancer Stage I, Breast Cancer Stage II N/A Interventional 24 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi) · Sponsor: Barbara Ann Karmanos Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT07218432)

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Hypertension, Pulmonary, Lung Diseases, Interstitial Phase 2 Interventional 25 participants sought
Allen Park — Allen Park, Michigan (10.3 mi) · Sponsor: Tectonic Operating Company, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07473700)

Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty

Osteoarthritis (OA) of the Knee Phase 4 Interventional 150 participants sought
Henry Ford Medical Center - Grosse Pointe Cottage — Grosse Pointe Farms, Michigan (10.9 mi) · Sponsor: Henry Ford Health System
See eligibility & contact on ClinicalTrials.gov (NCT07775248)

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Parkinson's Disease Phase 1 Interventional 124 participants sought
Quest Research Institute - Alcanza — Farmington Hills, Michigan (15.7 mi) · Sponsor: Prevail Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06565195)

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Aortic Stenosis Treated With TAVI, Aortic Diseases N/A Interventional 500 participants sought
Henry Ford Hospital — Detroit, Michigan (4.6 mi) · Sponsor: EnCompass Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06689839)

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Focal Onset Seizures Phase 2 Interventional 216 participants sought
Wayne State University - Detroit Medical Center — Detroit, Michigan (4.6 mi) · Sponsor: Supernus Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06798896)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Detroit, Michigan (4.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Wayne State University School of Medicine — Detroit, Michigan (4.6 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion) — Detroit, Michigan (4.6 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07062965)

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Sepsis, Acute Kidney Injury Phase 2 Interventional 124 participants sought
Research Site — Detroit, Michigan (4.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07215702)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Karmanos Cancer Institute — Detroit, Michigan (4.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection Recurrence Phase 2 Interventional 20 participants sought
Henry Ford Hospital — Detroit, Michigan (4.6 mi) · Sponsor: Acurx Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07513285)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Associated Retinal Consultants PC — Royal Oak, Michigan (7.6 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)
Actively enrolling

Studies you may be able to join near Detroit

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Detroit

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Trials Office, Karmanos Cancer Institute

★ 3.0
87 E Canfield St Storefront, Detroit, MI 48201
(313) 576-9790
"Never go to this place! They are very rude so is the dr and they are only about there money! Very very bad place"
— Danielle Goble, 1★

WSU Integrative Biosciences Center

★ 4.9
6135 Woodward Ave, Detroit, MI 48202
(313) 577-1771
"Great Staff, hopefully this tinnitus study and its results helps the millions of people that deal with this disease. 🙏"
— Thomas Ruszkiewicz Jr, 5★

Vitalis Clinical Research Center

★ 5.0
7445 Allen Rd #260, Allen Park, MI 48101
(313) 887-4536
"The ladies are very nice and professional. Kiya is the greatest. She explains everything to the fullest"
— Ace Boogie, 5★

Detroit Clinical Research Center

★ 5.0
30160 Orchard Lake Rd #110, Farmington Hills, MI 48334
(248) 737-5939

Mott Center For Human Growth

C. S. Mott Center for Human Growth and Development, 275 E Hancock St, Detroit, MI 48201
(313) 577-1485

Flourish Research - Detroit

★ 3.3
20755 Greenfield Rd #107, Southfield, MI 48075
(248) 864-5242
"My experience with them is one of deceit and changing of information as it fits them. They have the recruiters take your all history and medication h…"
— Marie Berry, 1★

DM Clinical Research-Detroit

★ 4.7
20180 W 12 Mile Rd Ste 400, Southfield, MI 48076
(313) 513-1616
"Very friendly very welcoming very nice overall"
— Aidan Nason, 5★

STARC Lab

3901 Chrysler Dr, Detroit, MI 48201

Henry Ford Cancer - Detroit

★ 4.2 (89 reviews)
2800 W Grand Blvd, Detroit, MI 48202
(888) 246-6424
"Hello,I really do not complain about customer service but in one of your department,they picked up the phone rude,and they had the nerve to hang up …"
— Melinda Alford, 1★

Clinical trials in Detroit: what's recruiting

The Detroit area currently has 1,198 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Detroit, the most active research areas are:

  • Cancer & Oncology11 studies
  • Lungs & Breathing2 studies
  • Heart & Vascular2 studies
  • Immune & Skin1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Detroit, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Detroit

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Detroit participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Detroit?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Detroit safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Detroit?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Detroit.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Detroit typically complete one or two studies per year.

Paid clinical trials near Detroit

Other metros within reach

South Lyon, MI1,324 Ann Arbor, MI1,177 Toledo, OH216 Flint, MI167 Lorain, OH1,314 Lansing, MI170 Cleveland, OH1,418 Akron, OH392

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Detroit Chronic Kidney Disease (HealthMatch) in Detroit Bladder Issues Due To Spinal Cord Injury in Detroit All conditions

More of MI

South Lyon1,324 Ann Arbor1,177 Grand Rapids465 Lansing170 Flint167 Kalamazoo102 Muskegon65

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts